SALMEX Inhalation powder, pre-dispensed Ref.[51131] Active ingredients: Fluticasone Salmeterol

Source: Medicines Authority (MT)  Revision Year: 2022  Publisher: Glenmark Pharmaceuticals Nordic AB, Propellergatan 2, SE-211 15 Malmö, Sweden

Product name and form

Salmex 50 microgram/500 microgram/dose inhalation powder, pre-dispensed.

Pharmaceutical Form

Inhalation powder, pre-dispensed.

Molded plastic inhaler containing a foil strip with 60 regularly placed blisters.

Qualitative and quantitative composition

Each single inhalation provides a delivered dose (the dose leaving the mouthpiece) of 47 micrograms of salmeterol (as salmeterol xinafoate) and 460 micrograms of fluticasone propionate. This corresponds to a pre-dispensed dose of 50 micrograms of salmeterol (as salmeterol xinafoate) and 500 micrograms fluticasone propionate.

Excipient(s) with known effect: Each dose contains lactose up to 13.3 milligram.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Fluticasone

Fluticasone has anti-inflammatory and vasoconstrictive features. Fluticasone given by inhalation at recommended doses has a potent glucocorticoid anti-inflammatory action within the lungs, resulting in a reduction of both symptoms and exacerbations of asthma, with a lower incidence and severity of adverse effects than those observed when corticosteroids are administered systemically.

Salmeterol

Salmeterol is a selective long-acting (12 hour) β2 adrenoceptor agonist. These pharmacological properties of salmeterol offer more effective protection against histamine-induced bronchoconstriction and produce a longer duration of bronchodilation, lasting for at least 12 hours, than recommended doses of conventional short-acting β2 agonists.

List of Excipients

Lactose monohydrate (which contains milk proteins)

Pack sizes and marketing

Blisters made from polyamide (OPA)/Aluminium/polyvinyl chloride (PVC)/Aluminium/polyethylene terephthalate (PET)/paper contained in a molded plastic inhaler equipped with a mouthpiece and dose counter. The inhaler is packed in a cardboard box.

One inhaler contains 60 inhalations.

The plastic devices are available in cardboard containers, which hold 1 × 60 dose, 2 × 60 dose, 3x 60 dose, 10 × 60 dose Salmex

Not all pack sizes may be marketed.

Marketing authorization holder

Glenmark Pharmaceuticals Nordic AB, Propellergatan 2, SE-211 15 Malmö, Sweden

Marketing authorization dates and numbers

MA1357/00101

05th November 2018

Drugs

Drug Countries
SALMEX Finland, Malta, Poland, Romania

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.